Rel-Mirogabalin Impurity 122 (Enantiomer Mixture) CAS 1234045-56-7

Description

Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Rel-Mirogabalin Impurity 122 (Enantiomer Mixture).

CATO supplies Rel-Mirogabalin Impurity 122 (Enantiomer Mixture) (CAS 1234045-56-7), a pharmacopoeial impurity reference standard (molecular formula C12H19NO2, MW 209.28 g/mol) used for the identification and quantification of trace impurities in APIs.

Rel-Mirogabalin Impurity 122 (Enantiomer Mixture) (C12H19NO2) contains an amino-acid-derived structure, an amide group, a hydroxyl group, an ether linkage. Its high carbon-to-hydrogen ratio confers good lipid solubility, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

As a certified reference material (CRM), Rel-Mirogabalin Impurity 122 (Enantiomer Mixture) meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com